Delivery Order SPE2DB22D2007-SPE2DB25FJ5BB
- Not listed
- The Defense Logistics Agency awarded a $9,112.43 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Xeljanz 5 mg tablets (60-count units). This is a firm fixed-price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a $28.8K delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on September 15, 2025, with completion scheduled for September 16, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $11,275.80, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 13, 2025. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on July 31, 2025, valued at $3,070.26 with a firm fixed price structure. The contract covers the delivery of Xeljanz 5 mg tablets in quantities of 60 units to support federal medical procurement needs. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $14,182.44 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,277.87 on May 30, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30-unit packages. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $24,078.22 to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $51,847.92 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a single...
- The Defense Logistics Agency awarded a $5,476.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on September 10, 2025, with completion scheduled for September 11, 2025. This non-set-aside delivery order represents a small-value pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,568.39 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-competitive delivery against the vendor's existing Indefinite Delivery Contract (IDC). The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5BBDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $44,855.48 for 60 tablets of Xeljanz 5 mg on September 17, 2025, with completion targeted for September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling value and extends through December 2026. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. Xeljanz is a prescription immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military and federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical distributor supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's DLA prime vendor contract serves as a comprehensive vehicle enabling delivery of a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.9k | 9/17/25 |